Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Reports In-Line Q1 EPS

May 9, 2022 4:51 PM EDT

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.63), in-line with the analyst estimate of ($0.63).

As of March 31, 2022, Syndax had cash, cash equivalents and short-term investments of $397.9 million and 59.0 million shares and share equivalents issued and outstanding. This includes 4.0 million pre-funded warrants.

For earnings... More